Medicus Pharma Ltd (NASDAQ:MDCX) | WebDisclosure

Switch to English

10001	Sociétés
202938	Mots-clés
133530	Articles
107757	Communiqués

Accueil
Sociétés
Medicus Pharma Ltd

COMMUNIQUÉ DE PRESSE

publié le 22/10/2025 à 13:30, il y a 4 mois 18 jours

Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Medicus Pharma enrolls first patient in SKNJCT-004 phase 2 clinical study for non-invasive BCC treatment in UAE with Cleveland Clinic Abu Dhabi as lead investigator

Clinical Study Medicus Pharma SKNJCT-004 BCC Treatment Cleveland Clinic Abu Dhabi
BRÈVE

publiée le 13/10/2025 à 13:35, il y a 4 mois 27 jours

Medicus Pharma Ltd. présentera au Maxim Growth Summit 2025

Conférence Sur Les Biotechnologies Medicus Pharma Teverelix Sommet Maxim Growth Injection Cutanée
BRÈVE

publiée le 13/10/2025 à 13:35, il y a 4 mois 27 jours

Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025

Biotech Conference Medicus Pharma Teverelix Maxim Growth Summit Skinject
COMMUNIQUÉ DE PRESSE

publié le 13/10/2025 à 13:30, il y a 4 mois 27 jours

Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer)

Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRÈVE

publiée le 07/10/2025 à 13:35, il y a 5 mois 2 jours

Medicus Pharma participera au sommet des family offices de Dubaï

Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRÈVE

publiée le 07/10/2025 à 13:35, il y a 5 mois 2 jours

Medicus Pharma to Participate in Dubai Family Office Summit

Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
COMMUNIQUÉ DE PRESSE

publié le 07/10/2025 à 13:30, il y a 5 mois 2 jours

Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE
Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai

Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRÈVE

publiée le 29/09/2025 à 13:35, il y a 5 mois 10 jours

Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject

Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
BRÈVE

publiée le 29/09/2025 à 13:35, il y a 5 mois 10 jours

Medicus Pharma Ltd. Gains FDA Support for Skinject Development

FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
COMMUNIQUÉ DE PRESSE

publié le 29/09/2025 à 13:30, il y a 5 mois 10 jours

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject
FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026

FDA Clinical Study Medicus Pharma Skinject D-MNA BCC

Les Echos

Publié le 09/03/2026 à 18:43, il y a 5 heures 22 minutes

Reporting on share buyback transactions carried out between March 2 and March 6, 2026
Publié le 09/03/2026 à 18:43, il y a 5 heures 22 minutes

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 2 au 6 mars 2026
Publié le 09/03/2026 à 18:21, il y a 5 heures 44 minutes

TERACT - EN REPONSE A L’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAR B DE LA SOCIÉTÉ TERACT
Publié le 09/03/2026 à 18:00, il y a 6 heures 5 minutes

CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Publié le 09/03/2026 à 18:00, il y a 6 heures 5 minutes

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 09/03/2026 à 21:50, il y a 2 heures 15 minutes

Jaguar Mining Receives Approval for Resumption of Operations at Its MTL Complex (Turmalina Mine), Brazil
Publié le 09/03/2026 à 21:10, il y a 2 heures 55 minutes

Zentek Provides PDAC 2026 Update - Government and First Nations Engagement
Publié le 09/03/2026 à 17:15, il y a 6 heures 50 minutes

Alta Copper Corp. and Nascent Exploration Pty Ltd Announce Completion of Plan of Arrangement
Publié le 09/03/2026 à 14:00, il y a 10 heures 5 minutes

urban-gro, Inc. Regains Full Nasdaq Compliance Following Balance Sheet and Governance Improvements
Publié le 09/03/2026 à 14:00, il y a 10 heures 5 minutes

Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants

Voir tout ACCESSWIRE

EQS Group

Publié le 09/03/2026 à 23:24, il y a 40 minutes

EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for 2025 of €225 million (+10% vs. 2024, lower end of the guidance) and adjusted EBITDA of €46 million (-29% vs. 2024, -7% vs. guidance)
Publié le 09/03/2026 à 21:05, il y a 3 heures

Demand for International Summer Schools Surges as Oxford Education Provider Named Among Europe's Fastest-Growing Companies
Publié le 09/03/2026 à 19:30, il y a 4 heures 34 minutes

Branicks Group AG intensifies talks with creditors of its promissory note loans maturing in March and April 2026 regarding short-term extension
Publié le 09/03/2026 à 19:26, il y a 4 heures 39 minutes

Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 09/03/2026 à 19:24, il y a 4 heures 41 minutes

EQS-Adhoc: Branicks Group AG intensifies talks with creditors of its promissory note loans maturing in March and April 2026 regarding short-term extension